Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Titan Pharmaceuticals Inc (NASDAQ:TTNP)

3.84
Delayed Data
As of Feb 05
 +0.06 / +1.59%
Today’s Change
2.57
Today|||52-Week Range
10.00
-13.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues912.0K911.0K760.0K0.00
 
 
 
 
Depreciation And Amortization88.0K89.0K88.0K88.0K
 
 
 
 
 
 
Operating ExpensesGross Income824.0K-----88.0K
 
 
 
General Expenses2.1M2.4M1.8M1.7M
 
 
 
 
 
Research And Development1.6M1.4M1.1M1.0M
 
 
 
 
 
Total Operating Expenses2.2M2.5M1.9M1.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.3M-1.6M-1.1M-1.8M
 
 
 
 
 
Extraordinary Credit770.0K0.000.000.00
 
 
Extraordinary Charge0.00-3.3M-1.2M-2.0K
 
 
 
 
Other Expenses10.0K-3.0K-4.0K-3.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-473.0K-4.9M-2.3M-1.8M
 
 
 
 
 
Net Income-473.0K-4.9M-2.3M-1.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.7M20.0M20.1M20.1M
 
 
 
 
 
Shares To Calculate EPS Diluted19.7M20.1M20.1M20.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.22-$0.11-$0.09
 
 
 
 
 
EPS Diluted-$0.06-$0.22-$0.11-$0.09